They announced positive top line results from their P3 trial. Adolescent and paediatric trials are happening both this month and next. Major competitors such as JNJ, PFE, NVS that require multiple pills a day for the same effect. Extremely large TAM. Buyout candidate? We have popped off of the bottom channel and are looking for 1.10. A breakout above that sends it to 1.40-1.50 range. This is my own opinion and shouldn't be taken as financial advice. Own your trades.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.